These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 33968710)

  • 21. Circulating noncoding RNAs: promising biomarkers in liquid biopsy for the diagnosis, prognosis, and therapy of NSCLC.
    Li Y; Ye J; Xu S; Wang J
    Discov Oncol; 2023 Aug; 14(1):142. PubMed ID: 37526759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracellular circulating miRNAs as potential non-invasive biomarkers in non-small cell lung cancer patients.
    Raczkowska J; Bielska A; Krętowski A; Niemira M
    Front Oncol; 2023; 13():1209299. PubMed ID: 37546401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances of microRNA-based molecular diagnostics to reduce false-positive lung cancer imaging.
    Boeri M; Sestini S; Fortunato O; Verri C; Suatoni P; Pastorino U; Sozzi G
    Expert Rev Mol Diagn; 2015 Jun; 15(6):801-13. PubMed ID: 25924864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating microRNA array (miR-182, 200b and 205) for the early diagnosis and poor prognosis predictor of non-small cell lung cancer.
    Zou JG; Ma LF; Li X; Xu FL; Fei XZ; Liu Q; Bai QL; Dong YL
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1108-1115. PubMed ID: 30779079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimizing the Detection of Circulating Markers to Aid in Early Lung Cancer Detection.
    Murlidhar V; Ramnath N; Nagrath S; Reddy RM
    Cancers (Basel); 2016 Jun; 8(7):. PubMed ID: 27367729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer.
    Tang Y; Qiao G; Xu E; Xuan Y; Liao M; Yin G
    Onco Targets Ther; 2017; 10():4527-4534. PubMed ID: 28979144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating RNAs as new biomarkers for detecting pancreatic cancer.
    Kishikawa T; Otsuka M; Ohno M; Yoshikawa T; Takata A; Koike K
    World J Gastroenterol; 2015 Jul; 21(28):8527-40. PubMed ID: 26229396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating miRNA-21 and miRNA-23a Expression Signature as Potential Biomarkers for Early Detection of Non-Small-Cell Lung Cancer.
    Hetta HF; Zahran AM; Shafik EA; El-Mahdy RI; Mohamed NA; Nabil EE; Esmaeel HM; Alkady OA; Elkady A; Mohareb DA; Hosni A; Mostafa MM; Elkady A
    Microrna; 2019; 8(3):206-215. PubMed ID: 30652656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular biomarkers in early stage lung cancer.
    Rodríguez M; Ajona D; Seijo LM; Sanz J; Valencia K; Corral J; Mesa-Guzmán M; Pío R; Calvo A; Lozano MD; Zulueta JJ; Montuenga LM
    Transl Lung Cancer Res; 2021 Feb; 10(2):1165-1185. PubMed ID: 33718054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lung cancer screening: from imaging to biomarker.
    Xiang D; Zhang B; Doll D; Shen K; Kloecker G; Freter C
    Biomark Res; 2013 Jan; 1(1):4. PubMed ID: 24252206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring the Potential of Non-Coding RNAs as Liquid Biopsy Biomarkers for Lung Cancer Screening: A Literature Review.
    Garbo E; Del Rio B; Ferrari G; Cani M; Napoli VM; Bertaglia V; Capelletto E; Rolfo C; Novello S; Passiglia F
    Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liquid Biopsy in Non-Small Cell Lung Cancer: Highlights and Challenges.
    Rijavec E; Coco S; Genova C; Rossi G; Longo L; Grossi F
    Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31861557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Liquid Biopsy for Lung Cancer: State of the Art, Limitations and Future Developments.
    Di Capua D; Bracken-Clarke D; Ronan K; Baird AM; Finn S
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of Circulating miRNA-17 and miRNA-222 Expression Profiles as Non-Invasive Biomarkers in Egyptian Patients with Non-Small-Cell Lung Cancer.
    Hetta HF; Zahran AM; El-Mahdy RI; Nabil EE; Esmaeel HM; Elkady OA; Elkady A; Mohareb DA; Mahmoud Mostafa M; John J
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1927-1933. PubMed ID: 31244320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.
    Coco S; Alama A; Vanni I; Fontana V; Genova C; Dal Bello MG; Truini A; Rijavec E; Biello F; Sini C; Burrafato G; Maggioni C; Barletta G; Grossi F
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28492516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study.
    Marquette CH; Boutros J; Benzaquen J; Ferreira M; Pastre J; Pison C; Padovani B; Bettayeb F; Fallet V; Guibert N; Basille D; Ilie M; Hofman V; Hofman P;
    Lancet Respir Med; 2020 Jul; 8(7):709-716. PubMed ID: 32649919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutational Profile from Targeted NGS Predicts Survival in LDCT Screening-Detected Lung Cancers.
    Verri C; Borzi C; Holscher T; Dugo M; Devecchi A; Drake K; Sestini S; Suatoni P; Romeo E; Sozzi G; Pastorino U; Boeri M
    J Thorac Oncol; 2017 Jun; 12(6):922-931. PubMed ID: 28302568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a serum miRNA panel for detection of early stage non-small cell lung cancer.
    Ying L; Du L; Zou R; Shi L; Zhang N; Jin J; Xu C; Zhang F; Zhu C; Wu J; Chen K; Huang M; Wu Y; Zhang Y; Zheng W; Pan X; Chen B; Lin A; Tam JKC; van Dam RM; Lai DTM; Chia KS; Zhou L; Too HP; Yu H; Mao W; Su D
    Proc Natl Acad Sci U S A; 2020 Oct; 117(40):25036-25042. PubMed ID: 32943537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Research progress regarding long-chain non-coding RNA in lung cancer: a narrative review.
    Yu P; He X; Lu F; Li L; Song H; Bian X
    J Thorac Dis; 2022 Aug; 14(8):3016-3029. PubMed ID: 36071788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic and prognostic value of plasma microRNA-195 in patients with non-small cell lung cancer.
    Su K; Zhang T; Wang Y; Hao G
    World J Surg Oncol; 2016 Aug; 14(1):224. PubMed ID: 27733164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.